Cell Source, Inc. (CLCS)
0.8365
+0.06
(+8.03%)
USD |
OTCM |
Apr 10, 16:00
Cell Source EPS Diluted (Quarterly) : -0.0153 for Dec. 31, 2024
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Atossa Therapeutics, Inc. | -1.270 |
| Abeona Therapeutics, Inc. | -0.3717 |
| Kiora Pharmaceuticals, Inc. | -1.732 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.3313M |
| Total Expenses (Quarterly) | 0.3313M |